EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Platelet-rich plasma in reproductive medicine: Bridging endometrial repair and maternal-fetal immune regulation

Yin Yin, Yilin Zhang, Chao Wang, Hong Zhang

Journal of Reproductive Immunology · 2026

DOI: 10.1016/j.jri.2026.104892 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Reproductive Immunology, 2026. Verfasst von Yin Yin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China. Hauptthemen laut MEDLINE: Platelet-Rich Plasma, Endometrium, Reproductive Medicine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Platelet-Rich Plasma (PRP) has emerged as a promising biological agent in reproductive medicine, with validated efficacy in managing endometrial disorders and improving pregnancy outcomes in recurrent implantation failure (RIF). Specifically, PRP modulates uterine Natural Killer (uNK) cell cytotoxicity, drives macrophage polarization toward the anti-inflammatory M2 phenotype through the AMPK signaling pathway, and fine-tunes T cell subset balance and function. These coordinated immunomodulatory actions, coupled with its endometrial repair capacity, collectively foster a maternal-fetal immune tolerance state critical for successful embryo implantation and pregnancy maintenance, thus providing a novel integrated strategy for reproductive disorders. However, the clinical translation of PRP is currently hindered by the lack of standardized preparation protocols and an incomplete elucidation of its precise molecular mechanisms underlying the crosstalk between endometrial repair and maternal-fetal immune regulation. We conclude that future research should focus on establishing disease-specific standardized PRP workflows and leveraging multi-omics technologies to decipher the core regulatory pathways of this bridging effect. This will pave the way for developing targeted therapies and optimizing the clinical application of PRP in reproductive medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Platelet-Rich PlasmaEndometriumReproductive MedicineFemaleHumansPregnancyEmbryo ImplantationAnimalsImmune ToleranceKiller Cells, NaturalImmunomodulation

Stichwörter der Autor:innen

Endometrial repairImmune regulationMaternal-fetal interfacePlatelet-rich plasma

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China.
  • Clinical Medicine Institute of Soochow University & Suzhou BenQ Medical Center, Suzhou 215011, China.
  • Institute of Functional Nano & Soft Materials (FUNSOM), Soochow University, Suzhou 215123, China. Electronic address: cwang@suda.edu.cn.
  • The Reproductive Medicine Center, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China. Electronic address: szzhanghong126@126.com.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yin, Y., Zhang, Y., Wang, C., & Zhang, H. (2026). Platelet-rich plasma in reproductive medicine: Bridging endometrial repair and maternal-fetal immune regulation. Journal of Reproductive Immunology. https://doi.org/10.1016/j.jri.2026.104892

Vancouver

Yin Y, Zhang Y, Wang C, Zhang H. Platelet-rich plasma in reproductive medicine: Bridging endometrial repair and maternal-fetal immune regulation. Journal of Reproductive Immunology. 2026. doi:10.1016/j.jri.2026.104892

BibTeX
@article{Yin2026,
  author = {Yin, Yin and Zhang, Yilin and Wang, Chao and Zhang, Hong},
  title = {Platelet-rich plasma in reproductive medicine: Bridging endometrial repair and maternal-fetal immune regulation},
  journal = {Journal of Reproductive Immunology},
  year = {2026},
  doi = {10.1016/j.jri.2026.104892}
}
Kostenlos starten →